» Articles » PMID: 2044316

Unusual Causes of I-131 Metaiodobenzylguanidine Uptake in Non-neural Crest Tissue

Overview
Journal Clin Nucl Med
Specialty Nuclear Medicine
Date 1991 Apr 1
PMID 2044316
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Three patients with clinical suspicion of pheochromocytoma were studied with metaiodobenzylguanidine (MIBG) labeled with I-123 or I-131. In these three patients, marked uptake of the radiopharmaceutical was demonstrated in tissues that were subsequently proven not to be of neural crest origin. Furthermore, extensive biochemical evaluations and long-term followup definitively excluded pheochromocytoma in all three. Therefore, these three cases represent unexpected "false-positive" MIBG uptake.

Citing Articles

Elevated I-MIBG activity in adrenocortical adenoma-what other imaging options do we have?.

Xia X, Wang K, Shao F, Hu F, Hu S, Dai Y Quant Imaging Med Surg. 2022; 12(4):2591-2595.

PMID: 35371959 PMC: 8923844. DOI: 10.21037/qims-21-904.


Recurrent bloody stools associated with visceral infantile haemangioma in a preterm twin girl.

Krick J, Riehle K, Chapman T, Chabra S BMJ Case Rep. 2018; 11(1).

PMID: 30567166 PMC: 6301538. DOI: 10.1136/bcr-2018-226564.


Adrenocortical Carcinoma: False Positive in an I-123 Metaiodobenzylguanedine Scan.

Rodriguez Rey C, Ortega Candil A, Vano Galvan E, Cabrera Martin M, Carreras Delgado J Nucl Med Mol Imaging. 2016; 50(2):166-8.

PMID: 27275368 PMC: 4870452. DOI: 10.1007/s13139-015-0343-3.


False-positive radio-iodinated metaiodobenzylguanidine (123I-MIBG) accumulation in a mast cell-infiltrated infantile haemangioma.

Rottenburger C, Juettner E, Harttrampf A, Hentschel M, Kontny U, Roessler J Br J Radiol. 2010; 83(992):e168-71.

PMID: 20675460 PMC: 3473506. DOI: 10.1259/bjr/40750533.


Routine preoperative (123)I-MIBG scintigraphy for patients with phaeochromocytoma is not necessary.

Mihai R, Gleeson F, Roskell D, Parker A, Sadler G Langenbecks Arch Surg. 2008; 393(5):725-7.

PMID: 18663465 DOI: 10.1007/s00423-008-0387-2.